| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |